Dillan Madhani

Dillan is an Associate in the Corporate and Life Sciences group in London. He specialises in advising companies and investors in the technology and life sciences sector on venture capital investments, M&A transactions and general corporate matters.

CV

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

2022 - 2022 Paralegal, Taylor Wessing

职业发展

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

2022 - 2022 Paralegal, Taylor Wessing

教育

2024 Admitted as a lawyer, England and Wales

2022 Master of Laws, BPP University (London)

2022 Legal Practice Course, BPP University (London)

最新新闻和观点

View Dillan's insights

点击此处了解更多

公司/并购与资本市场

Advising Rezolve AI on its US$230 million acquisition of Reward Loyalty UK Limited

2026年2月12日

作者

公司/并购与资本市场

Advising Lingotto on its extended Series A funding into Optalysys to US$60 million

2026年2月6日

作者

点击此处了解更多

专长

执业领域和服务团队

行业

CV

职业发展

教育

最新新闻和观点

Advising Rezolve AI on its US$230 million acquisition of Reward Loyalty UK Limited

Dillan Madhani

专长

执业领域和服务团队

行业

CV

职业发展

教育

最新新闻和观点

Advising Rezolve AI on its US$230 million acquisition of Reward Loyalty UK Limited

Related news & insights

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act

Proposed Amendments to the EU Medical Device Regulation

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

Impact of the new Biotech Act on Clinical Trials in the EU

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

Climate-based claims against car manufacturers: The Federal Court of Justice (BGH) has dismissed the climate lawsuits brought by DUH

Advising on Sona's US$45 million Series B funding

Life Sciences Legal Lens – Vol. 1

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

相关人员

与我会面：